Acadia Pharmaceuticals buy BiotechBee
Start price
03.01.23
/
60%
€15.65
Target price
31.12.25
€22.00
Performance (%)
23.98%
End price
05.05.23
€19.40
Summary
This prediction ended on 05.05.23 with a price of €19.40. The BUY prediction by BiotechBee finished with a performance of 23.98%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acadia Pharmaceuticals | -7.878% | -7.878% | 12.799% | -5.981% |
| iShares Core DAX® | -2.117% | -7.974% | -1.733% | 53.340% |
| iShares Nasdaq 100 | -1.323% | -0.066% | 16.602% | 81.164% |
| iShares Nikkei 225® | -0.324% | -6.382% | 25.629% | 52.301% |
| iShares S&P 500 | -1.568% | -1.965% | 10.831% | 60.913% |
According to BiotechBee what are the pros and cons of Acadia Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Acadia Pharmaceuticals diskutieren
Buy mit Kursziel 22,0
In the thread Trading Acadia Pharmaceuticals
Buy beendet

